Dr. Newell is an emerging leader in the field of immune cell characterization with a stellar publication record. He has pioneered a technology that includes CyTOF with heavy-metal tagged antibody staining that could have major implications in understanding immunity and cancer. Dr. Newell’s research is based on innovative techniques and will yield an unprecedented in-depth characterization of epitope usage by T-cell populations in cancer and chronic infections, which can potentially lead to novel discoveries in the field of cancer immunology.